ANAPTYSBIO INC
ANAB · NASDAQ
更新於 2026-10-14 12:07:47
$45.59-0.97%
- 今日最高
- $46.12
- 今日最低
- $45.15
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $46.16
- 昨天收盤價
- $46.04
- 成交量
- 371.65K
- 市值
- $1.37B
- 市盈率（P/E）
- 7.05X
- 每股收益（EPS）
- $3.34
昨天價格區間
$45.98$46.78
52週價格區間
$20.18$72.36
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 生物科技
- 總部
- 10770 WATERIDGE CIRCLE, SAN DIEGO, CA, UNITED STATES, 92121
- 國家
- 美國
- 上市日期
- 2017-01-26
- 財年截止
- 十二月
- 流通股數
- 29.61M
- CIK
- 0001370053
AnaptysBio, Inc.是一家臨床階段生物技術公司，致力於開發用於炎症及免疫腫瘤適應症的治療性候選產品。公司總部位於加州聖地牙哥。
財務指標
營業收入
2026-06-30
$27.48M
2026-03-31
$25.55M
2025-12-31
$108.24M
2025-09-30
$76.32M
營業支出
2026-06-30
$10.63M
2026-03-31
$59.58M
2025-12-31
$149.33M
2025-09-30
$10.2M
淨利潤
2026-06-30
$183.88M
2026-03-31
-$52.88M
2025-12-31
$49.61M
2025-09-30
$15.11M
淨利潤率
2026-06-30
668.94%
2026-03-31
-206.93%
2025-12-31
45.83%
2025-09-30
19.8%
每股收益
2026-06-30
$-0.11
2026-03-31
$-1.84
2025-12-31
$1.58
2025-09-30
$0.52
息稅折舊攤銷前利潤
2026-06-30
$15.03M
2026-03-31
-$31.37M
2025-12-31
$70.01M
2025-09-30
$38.23M
有效稅率
2026-06-30
-380.07%
2026-03-31
-0.07%
2025-12-31
0.16%
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $27.48M | $25.55M | $108.24M | $76.32M |
| 營業支出 | $10.63M | $59.58M | $149.33M | $10.2M |
| 淨利潤 | $183.88M | -$52.88M | $49.61M | $15.11M |
| 淨利潤率 | 668.94% | -206.93% | 45.83% | 19.8% |
| 每股收益 | $-0.11 | $-1.84 | $1.58 | $0.52 |
| 息稅折舊攤銷前利潤 | $15.03M | -$31.37M | $70.01M | $38.23M |
| 有效稅率 | -380.07% | -0.07% | 0.16% | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。